Health and Healthcare Systems

The organ shortage will soon get worse. Could animals help? 

Medical team perform a heart surgery in an operating room at the Saint-Augustin clinic in Bordeaux, France, October 25. REUTERS/Regis Duvignau - RC1BB53A1010

75,000 Americans need an organ transplant. Image: REUTERS/Regis Duvignau

Kristin Houser
Writer, Futurism

Bad to worse

Nearly 75,000 Americans need an organ transplant. Of those, an estimated 18 will die today because they didn’t get one soon enough.

The bottom line is that there just aren’t enough donor organs available to meet the nation’s need. Soon, in a strange twist, self-driving cars could exacerbate the problem by reducing the number of car accidents, which is currently one of the primary sources of donor organs.

Image: U.S. Department of Health and Human Services


Researchers across the globe are hunting for ways to save patients. And now, an idea previously relegated to the realm of science fiction is starting to look like a viable option: transplanting organs from animals into humans.

“I think this is a magical point in the field of [animal transplants],” biotech researcher William Westlin told The Guardian. “It’s no longer a question of if. It’s just a question of when.”

Organ rejected

Convincing the human body to accept a donated organ isn’t easy — the body’s natural response is to view the organ as something foreign, which causes the immune system to swoop into action to eliminate it.

Doctors have found ways to stifle that response with medication, but it doesn’t always prevent the recipient’s body from refusing to accept the donated organ.

Now imagine the issues that can arise from trying to introduce an organ from another species — and not just another human — into the mix, and you can see why xenotransplantation, the technical name for cross-species organ transplants, was considered impossible for so long.

Have you read?

Pigs And primates

Thanks to the latest breakthroughs in science and medicine, though, xenotransplantation is starting to look feasible for the first time ever.

The biotech company where Westlin works, eGenesis, used CRISPR to remove viruses from the pig genome that might harm a human that received an organ from the animal. Now it’s attempting to use the gene-editing technology to remove markers from pig cells that identify them as foreign, thereby decreasing the possibility of triggering an immune response in humans.

And by developing a new pre-transplantation treatment for pig hearts, a team from Germany was able to keep baboons transplanted with the foreign organs alive for months in 2018 — an important milestone along the path to transplanting animal organs into humans.

Meanwhile, researchers at the University of Alabama at Birmingham (UAB) have trials planned to transplant genetically engineered pig kidneys and hearts into humans within the next few years.

“It’ll revolutionise medicine when it comes in,” David Cooper, co-director of UAB’s xenotransplantation program, told The Guardian in reference to transplantable animal organs. “You’d have these organs available whenever you want them… If somebody’s had a heart attack, you could take their heart out and put a pig heart in on the spot. There is huge potential here.”

Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

Sign up for free

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Stay up to date:

Biotechnology

Share:
The Big Picture
Explore and monitor how Biotechnology is affecting economies, industries and global issues
A hand holding a looking glass by a lake
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
World Economic Forum logo
Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

The key health achievements of COP29, and other top health stories

Shyam Bishen

November 20, 2024

How equitable access to medicines can drive sustainable returns for investors

About us

Engage with us

  • Sign in
  • Partner with us
  • Become a member
  • Sign up for our press releases
  • Subscribe to our newsletters
  • Contact us

Quick links

Language editions

Privacy Policy & Terms of Service

Sitemap

© 2024 World Economic Forum